ISEQ in negative territory

The ISEQ index of Irish shares managed to recover from heavy losses this morning, but this did not stop them finishing in the red today, down 19.65 points to 7405.13.

Pharmaceutical company Elan fell 27c to €11.53 following the announcement that they and Biogen Idec have received notification from the US Food and Drug Administration (FDA) that the Peripheral and Central Nervous System Drugs Advisory Committee will review drug Tysabri for the treatment of multiple sclerosis on March 7.